Jessica Wenthe from Uppsala University presented Lokon Pharma's research at the European Society for Medical Oncology (ESMO) in Munich and was awarded the Best Poster in the immunotherapy session. Congratulations Jessica!
April 27, 2018
The first patient has been enrolled in the LOAd703 clinical trial in Sweden, LOKON002, for the treatment of pancreatic, biliary, colorectal, and ovarian cancer.
December 2, 2016
Our LOAd703 clinical trial in LOKON001 for patients with pancreatic cancer in Houston, TX, USA has now enrolled their first patient!
We have been informed that individuals are receiving fraudulent job interview invitations claiming to be from Lokon Pharma. Please be aware that Lokon Pharma is not conducting any recruitment or job interviews at this time. Any message, email, or phone call offering an interview or job opportunity with our company is not legitimate.
If you receive such communication, do not respond, do not provide any personal information, and do not send any money. These contacts are part of an ongoing scam.
For your safety, please report suspicious messages to your local authorities